VACOP-B vs VACOP-B+ABMT for aggressive non-Hodgkin's lymphoma. Results of a prospective randomised trial.

被引：0
|
作者：
Santini, G [1 ]
Salvagno, L [1 ]
Leoni, P [1 ]
Chisesi, T [1 ]
Rizzoli, V [1 ]
机构：
[1] S Martino Hosp, Dept Haematol, Genova, Italy
来源：
EXPERIMENTAL HEMATOLOGY | 1998年 / 26卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
234
引用
收藏
页码：746 / 746
页数：1
相关论文
共 50 条
  • [21] CHEMOTHERAPY WITH MACOP-B AND VACOP-B FOR INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - CLINICAL-RESULTS AND ANALYSIS OF PROGNOSTIC FACTORS
    PICHERT, G
    PETERS, J
    STAHEL, RA
    DOMMANN, C
    JOSS, R
    GEBBERS, JO
    KRONER, T
    SULSER, H
    HONEGGER, HP
    MAURER, R
    PAMPALLONA, S
    ANNALS OF ONCOLOGY, 1992, 3 (08) : 645 - 649
  • [22] Immunotherapeutic concepts for aggressive B-cell non-Hodgkin's Lymphoma
    Krackhardt, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 10 - 11
  • [23] Phase I-II trial of VACOP-B plus filgrastim (G-CSF) support for HIV-related non-Hodgkins lymphoma (NHL).
    Crump, M
    Shepherd, FA
    Routy, JP
    Walker, I
    St Louis, J
    Brandwein, J
    Taylor, M
    Meyer, RM
    Sawka, CA
    BLOOD, 2000, 96 (11) : 138A - 138A
  • [24] Sarcopenia and clinical evaluation in predicting treatment tolerability and outcomes in aggressive non-Hodgkin B cell lymphoma.
    Drory, Samuel Bernard
    Forget, Marie-France
    Wang, Han Ting
    Fleury, Isabelle
    Ahmad, Imran
    Marchand, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] Hepatitis c virus infection and B-cell non-Hodgkin's lymphoma.
    Grudeva, JG
    BLOOD, 2005, 106 (11) : 247B - 247B
  • [26] Chemokine upregulation in response to rituximab in B-cell non-Hodgkin's lymphoma.
    Ansell, SM
    Tschumper, RC
    Witzig, TE
    Kurtin, PJ
    Jelinek, DF
    BLOOD, 1999, 94 (10) : 86A - 86A
  • [27] Radiation dose in non-Hodgkin's lymphoma: Preliminary results of UKNCRN randomised trial
    Hoskin, P
    ANNALS OF ONCOLOGY, 2005, 16 : 51 - 51
  • [28] Final results of the phase II trial of paclitaxel plus oral estramustine phosphate in patients with relapsed aggressive non-Hodgkin's Lymphoma.
    Borghaei, H
    Millenson, MM
    Schilder, RJ
    Rogatko, A
    Alden, M
    Wang, H
    Padavic-Shaller, KA
    Minnitti, C
    Smith, MR
    BLOOD, 2003, 102 (11) : 293B - 293B
  • [29] Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma.
    Zuckerman, T
    Zuckerman, E
    Douer, D
    Fong, TL
    Nathwani, BN
    Velankar, M
    Gutekunst, K
    Qian, GD
    Levine, AM
    BLOOD, 1996, 88 (10) : 877 - 877
  • [30] Clinical trials of dendritic cell vaccination for B-cell non-Hodgkin's lymphoma.
    Timmerman, JM
    Davis, TA
    Hsu, FJ
    Benike, C
    Liles, TM
    Czerwinski, D
    Taidi, B
    van Beckhoven, A
    Fazio, M
    Engleman, EG
    Levy, R
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 15 - 15
12345